Intrathecal drug administration via lumbar puncture and a spinal access port device led to serious complications in a patient receiving experimental therapy for Niemann-Pick type C. In a case report ...
Eli Lilly is plowing a further $50 million into its research collaboration with Purdue University, signing up to work with its partner for another five years on challenges including intrathecal and ...
Feasibility of a self-administered geriatric assessment tool for older patients with cancer No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2006 ASCO ...
Credit: Getty Images. Researchers conducted a retrospective cohort study to assess the impact of an implantable pump on opioid consumption in patients with chronic noncancer pain. Use of an ...
Panelists discuss how intrathecal delivery of onasemnogene abeparvovec in the STEER study demonstrates statistically significant motor function improvements in older patients with SMA (ages 2-18 years ...
Fixed dose-rate gemcitabine infusion as first-line treatment for advanced-stage carcinoma of the pancreas and biliary tree: series of 106 consecutive patients No significant financial relationships to ...
Brain Trust Bio Inc. (BTB) will soon begin phase I trials in Australia of its IT-Riluzole delivered to the brain via a continuous intrathecal drug delivery method in people with amyotrophic lateral ...
Biogen has partnered with Alcyone Therapeutics to improve the delivery of its spinal muscular atrophy drug Spinraza, handing over $10 million upfront for a global license to an implantable device.
Oligonucleotide (oligo) therapies have been in development for decades. Recent advances in molecular design, chemistry, delivery systems, targeted delivery, reduced immunogenicity, and enhanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results